Ernexa Therapeutics Inc. (ERNA) Net margin 2016–2025
Ernexa Therapeutics Inc. (ERNA) net profit margin by fiscal year — reported net income divided by reported revenue.
-2419.9%FY2025 · since FY2016: -11.9% → -2419.9%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -2419.9% | +63078.6 pp |
| FY2024 | -65498.5% | — |
| FY2021 | -2112.8% | -2076.0 pp |
| FY2020 | -36.8% | -28.0 pp |
| FY2019 | -8.8% | -7.6 pp |
| FY2018 | -1.2% | +3.6 pp |
| FY2017 | -4.8% | +7.1 pp |
| FY2016 | -11.9% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More ERNA financial trends
ERNA RevenueERNA Net incomeERNA Gross profitERNA Gross marginERNA Operating incomeERNA Operating marginERNA Operating cash flowERNA Free cash flowERNA Capital expendituresERNA Return on equityERNA Stock buybacksERNA Dividends paidERNA Total assetsERNA Total liabilitiesERNA Shareholders’ equityERNA overview →